Article Information
History
- June 16, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marion Kibler, MD1,
- Adrien Carmona, MD1,
- Benjamin Marchandot, MD1,
- Kensuke Matsushita, MD1,2,
- Antonin Trimaille, MD1,
- Mohamad Kanso, MD1,
- Laurent Dietrich, MD1,
- Cécile How-Choong, MD1,
- Albane Odier, MD1,
- Gabrielle Gennesseaux, MD1,
- Ophélie Schramm, MD1,
- Antje Reydel, MD1,
- Michel Kindo, MD, PhD4,
- Minh Hoang, MD4,
- Sébastien Hess, MD1,
- Chisato Sato, MD, PhD1,
- Sophie Caillard, MD, PhD3,
- Laurence Jesel, MD, PhD1,2,
- Olivier Morel, MD, PhD1,2 and
- Patrick Ohlmann, MD, PhD1,*
- 1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
- 2INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France
- 3Division of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France
- 4Division of Cardiac Surgery, Strasbourg University Hospital, Strasbourg, France
- ↵*Correspondence:
Patrick Ohlmann, MD, PhD, Pôle d’Activité Médico-Chirurgicale Cardiovasculaire, Nouvel Hôpital Civil, BP 426 - 67091, Strasbourg, France, Fax: +33 369551736 ; phone: +33 369550953, E-mail: patrick.ohlmann{at}chru-strasbourg.fr
Posted June 16, 2020.
Risk and severity of COVID-19 and ABO blood group in transcatheter aortic valve patients
